These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 15915345)

  • 21. [Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy].
    Scheinmann P; Pham Thi N; Karila C; de Blic J
    Arch Pediatr; 2012 Mar; 19(3):330-4. PubMed ID: 22306361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in specific immunotherapy for allergic rhinitis.
    Bousquet J; Hejjaoui A; Michel FB
    Clin Exp Allergy; 1991 Jan; 21 Suppl 1():259-61. PubMed ID: 2032157
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunotherapy.
    Osguthorpe JD
    Curr Opin Otolaryngol Head Neck Surg; 2010 Jun; 18(3):206-12. PubMed ID: 20389246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sublingual immunotherapy.
    Lin SY; Leatherman B
    Otolaryngol Clin North Am; 2011 Jun; 44(3):753-64, x-xi. PubMed ID: 21621059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allergen immunotherapy in allergic rhinitis: current use and future trends.
    Klimek L; Pfaar O; Bousquet J; Senti G; Kündig T
    Expert Rev Clin Immunol; 2017 Sep; 13(9):897-906. PubMed ID: 28532268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific immunotherapy in allergic rhinitis.
    Mortuaire G; Michel J; Papon JF; Malard O; Ebbo D; Crampette L; Jankowski R; Coste A; Serrano E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Sep; 134(4):253-258. PubMed ID: 28684084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sublingual immunotherapy in children with allergic polysensitization.
    Ciprandi G; Cadario G; Di Gioacchino GM; Gangemi S; Gasparini A; Isola S; Marengo F; Minelli S; Ricciardi L; Ridolo E; Pravettoni V; Valle C; Verini M; Zambito M; Incorvaia C; Puccinelli P; Scurati S; Frati F; Simonetta M
    Allergy Asthma Proc; 2010; 31(3):227-31. PubMed ID: 20615323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future advances of immunotherapy.
    Nelson HS
    Allergy Asthma Proc; 2001; 22(4):203-7. PubMed ID: 11552669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
    Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
    J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
    Wolthers OD; Høst A; Frederiksen B; Halken S
    Ugeskr Laeger; 2012 Aug; 174(35):1989-92. PubMed ID: 22929576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.
    Bousquet J; Schünemann HJ; Bousquet PJ; Bachert C; Canonica GW; Casale TB; Demoly P; Durham S; Carlsen KH; Malling HJ; Passalacqua G; Simons FE; Anto J; Baena-Cagnani CE; Bergmann KC; Bieber T; Briggs AH; Brozek J; Calderon MA; Dahl R; Devillier P; Gerth van Wijk R; Howarth P; Larenas D; Papadopoulos NG; Schmid-Grendelmeier P; Zuberbier T
    Allergy; 2011 Jun; 66(6):765-74. PubMed ID: 21496059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current status of allergen-specific immunotherapy on perennial allergic rhinitis].
    Okano M
    Arerugi; 2008 Feb; 57(2):79-85. PubMed ID: 18349581
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical bystander effect exerted by allergen immunotherapy: a hypothesis.
    Ciprandi G
    Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):62-3. PubMed ID: 25781197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
    Campbell DE
    Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
    Tahamiler R; Saritzali G; Canakcioglu S
    Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practice parameters for sublingual immunotherapy.
    Ortolani C; Agostinis F; Amoroso S; Ariano R; Barbato A; Bassi M; Cadario G; Campi P; Cardinale F; Ciprandi G; D'Anneo R; Di Gioacchino M; Di Rienzo V; Fiocchi A; Galimberti M; Galli E; Giovannini M; Incorvaia C; La Grutta S; Lombardi C; Marcucci F; Marseglia G; Minelli M; Musarra A; Nettis E; Novembre E; Pajno G; Patriarca G; Pezzuto F; Piras P; Pucci S; Romano A; Romano C; Quercia O; Scala G; Schiavino D; Senna G; Sforza G; Tosca M; Tripodi S; Frati F
    Monaldi Arch Chest Dis; 2006 Mar; 65(1):44-6. PubMed ID: 16700194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
    Cochard MM; Eigenmann PA
    J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
    [No Abstract]   [Full Text] [Related]  

  • 39. Allergen-specific immunotherapy for allergic rhinitis: a new insight into its clinical efficacy and mechanism.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():178-90. PubMed ID: 9879418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
    Polzehl D; Keck T; Riechelmann H
    Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.